bupropion has been researched along with Abnormality, Heart in 5 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
Excerpt | Relevance | Reference |
---|---|---|
"Reports from the GlaxoSmithKline Bupropion Pregnancy Registry suggested an increase in cardiovascular defects following exposure to bupropion during pregnancy." | 7.74 | Bupropion in pregnancy and the prevalence of congenital malformations. ( Cole, JA; Cosmatos, IS; Haight, BR; Modell, JG; Stoler, JM; Walker, AM, 2007) |
"(3) An increased risk of birth defects, particularly cardiac malformations, is also suspected after exposure to amphetamine derivatives during pregnancy." | 5.33 | Bupropion (amfebutamone): caution during pregnancy. ( , 2005) |
" Exposure categories included first-trimester bupropion alone or in combination with other antidepressants, first-trimester antidepressants other than bupropion, and no exposure to any antidepressant at any time from 2 months prior to pregnancy through delivery." | 3.80 | First-trimester exposure to bupropion and risk of cardiac malformations. ( Kerr, S; Louik, C; Mitchell, AA, 2014) |
"Bupropion, an amphetamine, is authorised as an aid to smoking cessation, despite its negative harm-benefit balance." | 3.78 | Bupropion: congenital heart defects (continued). ( , 2012) |
"We sought to determine if maternal bupropion treatment in early pregnancy is associated with congenital heart defects in the infant." | 3.76 | Maternal use of bupropion and risk for congenital heart defects. ( Alwan, S; Botto, LD; Correa, A; Friedman, JM; Rasmussen, SA; Reefhuis, J, 2010) |
"Reports from the GlaxoSmithKline Bupropion Pregnancy Registry suggested an increase in cardiovascular defects following exposure to bupropion during pregnancy." | 3.74 | Bupropion in pregnancy and the prevalence of congenital malformations. ( Cole, JA; Cosmatos, IS; Haight, BR; Modell, JG; Stoler, JM; Walker, AM, 2007) |
"(3) An increased risk of birth defects, particularly cardiac malformations, is also suspected after exposure to amphetamine derivatives during pregnancy." | 1.33 | Bupropion (amfebutamone): caution during pregnancy. ( , 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Louik, C | 1 |
Kerr, S | 1 |
Mitchell, AA | 1 |
Alwan, S | 1 |
Reefhuis, J | 1 |
Botto, LD | 1 |
Rasmussen, SA | 1 |
Correa, A | 1 |
Friedman, JM | 1 |
Cole, JA | 1 |
Modell, JG | 1 |
Haight, BR | 1 |
Cosmatos, IS | 1 |
Stoler, JM | 1 |
Walker, AM | 1 |
5 other studies available for bupropion and Abnormality, Heart
Article | Year |
---|---|
First-trimester exposure to bupropion and risk of cardiac malformations.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Antidepressive Agents, Second-Generation; Bupropion; | 2014 |
Maternal use of bupropion and risk for congenital heart defects.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Case-Control Studies; Chi-Square Distrib | 2010 |
Bupropion: congenital heart defects (continued).
Topics: Bupropion; Dopamine Uptake Inhibitors; Drug Monitoring; Female; Heart Defects, Congenital; Humans; I | 2012 |
Bupropion (amfebutamone): caution during pregnancy.
Topics: Amphetamines; Antidepressive Agents, Second-Generation; Bupropion; Congenital Abnormalities; Contrai | 2005 |
Bupropion in pregnancy and the prevalence of congenital malformations.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Bupropion; Congenital Abnormalities; Da | 2007 |